Abstract:Purpose: The presence of pathogenic germline mutation in BRCA1 gene is considered as the most penetrant genetic predisposition for breast cancer. However, a portion of BRCA1 mutation carriers never develops breast cancer throughout their lifetime. This phenomenon is called incomplete penetrance. Genetic factor is proposed to contribute to this phenomenon, but the details regarding the genetic factor remain elusive. BRCA1 mutations were inherited from the ancestors of the mutation carrier families during human evolution, and their presence is a consistent threat to the survival of the mutation carrier population. In the present study, we hypothesize that evolution could positively select genetic components in the mutation carrier population to suppress the oncogenesis imposed by the predisposition. Experimental design: To test our hypothesis, we used whole exome sequencing to compare germline variation of all genes in pairs of breast cancer-unaffected and breast cancer-affected BRCA1 mutation carriers, each pair was from the same family carrying the same BRCA1 mutation. Results: We identified a group of 'beneficial' variants enriched in the breast cancer-unaffected carrier group. These were the common variants inhuman population distributed in multiple genes involved in multiple functionally important pathways. We found a single-nucleotide polymorphism, rs3735400 located in ANLN gene, which plays an essential role in controlling cytokinesis and is often found to be overexpressed in cancer. The carriers of this variant had lower cumulative risk of developing breast cancer; overexpression of the variant-containing ANLN decreased ANLN nuclear localization suppressed expression of the variant-containing ANLN, and decreased the cellular proliferation respectively. Conclusion: Our findings support our hypothesis that common genetic variants can be evolutionarily selected in BRCA1 mutation carrier population to counterpart the oncogenic effects imposed by mutation predisposition in BRCA1, contributing to the incomplete penetrance. (C) 2018 Elsevier Ltd. All rights reserved.

Clustering of predicted loss-of-function variants in genes linked with monogenic disease can explain incomplete penetrance

Dissecting the Reduced Penetrance of Putative Loss-of-Function Variants in Population-Scale Biobanks

Exploring penetrance of clinically relevant variants in over 800,000 humans from the Genome Aggregation Database

How do stochastic processes and genetic threshold effects explain incomplete penetrance and inform causal disease mechanisms?

Common Genetic Variants Contribute to Incomplete Penetrance: Evidence from Cancer-Free BRCA1 Mutation Carriers.

Guidance for estimating penetrance of monogenic disease-causing variants in population cohorts

Regional nonsense constraint offers clinical and biological insights into rare genetic disorders

Investigating the role of common cis-regulatory variants in modifying penetrance of putatively damaging, inherited variants in severe neurodevelopmental disorders

Prediction of Functional Regulatory SNPs in Monogenic and Complex Disease.

Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions

Inferring the Functional Effects of Mutation Through Clusters of Mutations in Homologous Proteins.

Transcript-aware analysis of rare predicted loss-of-function variants in the UK Biobank elucidate new isoform-trait associations

Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort

When a "Disease-Causing Mutation" is Not a Pathogenic Variant.

Rare penetrant mutations confer severe risk of common diseases

Functional categorization of gene regulatory variants that cause Mendelian conditions

Predictive modeling provides insight into the clinical heterogeneity associated with loss-of-function mutations

A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes

Gene-specific machine learning for pathogenicity prediction of rare BRCA1 and BRCA2 missense variants

Characterizing the pathogenicity of genetic variants: the consequences of context